Brief: Suzhou Basecare Medical Expects H1 Revenue To Rise 24%-29% Y/Y
BRIEF-Suzhou Basecare Medical Expects H1 Revenue To Rise 24%-29% Y/Y Aug 16 (Reuters) - Suzhou Basecare Medical Corp Ltd 2170.HK:
EXPECTS H1 REVENUE TO RISE 24%-29% Y/Y
Further company coverage: 2170.HK
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on Suzhou Basecare Medical
See all newsBrief: Suzhou Basecare Medical Says Repurchase H Shares For Up To RMB5 Million
Brief: Suzhou Basecare Medical Says Basecare-B Obtains NMPA Class III Device Certificates For Gems Vitrification And Warming Sets
Brief: Suzhou Basecare Medical Expects H1 Revenue To Rise 24%-29% Y/Y
Brief: Suzhou Basecare Medical Obtains NMPA Approval For Class III Medical Device Registration For GEMS Egg Retrieval Solution
Brief: Suzhou Basecare Medical Corp Gets NMPA Class III Device Approval For Gems Cleavage Embryo Culture Medium